A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)

Stopped Sponsor made a business decision to discontinue the study due to low accrual.

Conditions

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Primary Peritoneal Carcinoma
• High Grade Serous Carcinoma
• Endometrioid Adenocarcinoma

Interventions

• DRUG: Rucaparib
• DRUG: Nivolumab

Sponsor

pharmaand GmbH

Collaborators

• [object Object]
• [object Object]